Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

4-Hydroxybutyric aciduria

Z Rahbeeni1, P T Ozand, M Rashed

  • 1Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

Brain & Development
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and phenotypic characterization of NKX6-2-related spastic ataxia and hypomyelination.

European journal of neurology·2019
Same author

Mutations in known disease genes account for the majority of autosomal recessive retinal dystrophies.

Clinical genetics·2018
Same author

Extended right hemicolectomy and left hemicolectomy for colorectal cancers between the distal transverse and proximal descending colon.

Annals of the Royal College of Surgeons of England·2016
Same author

X-linked adrenoleukodystrophy. The Saudi experience.

Neurosciences (Riyadh, Saudi Arabia)·2013
Same author

Smith-Lemli-Opitz syndrome among Arabs.

Clinical genetics·2011
Same author

Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria.

Clinical genetics·2011
Same journal

Receptor-specific dopaminergic imbalance and sensory gating in Lesch-Nyhan syndrome.

Brain & development·2026
Same journal

From weather stations to the home environment: Refining seizure prediction in pediatric drug-resistant epilepsy.

Brain & development·2026
Same journal

Pediatric GBS-myelitis overlap syndrome: Severe phenotype, treatment response, and neurological outcomes.

Brain & development·2026
Same journal

Aspartoacylase (ASPA) gene mutations and neuroimaging features in Iranian patients with Canavan disease: a descriptive study.

Brain & development·2026
Same journal

Third nationwide survey of bilirubin encephalopathy in preterm infants in Japan.

Brain & development·2026
Same journal

Urine protein/osmolality and creatinine/osmolality ratios for assessing proteinuria and motor function in children with spinal muscular atrophy.

Brain & development·2026
See all related articles

4-hydroxybutyric aciduria is a rare genetic disorder causing severe developmental delay and seizures in infants. Vigabatrine treatment reduced acid levels but showed limited clinical improvement in most patients.

Area of Science:

  • Biochemistry
  • Genetics
  • Neurology

Background:

  • 4-hydroxybutyric aciduria is a rare metabolic disorder.
  • Characterized by severe neurological impairment in infancy.

Observation:

  • Six patients from three families presented with global delay, hypotonia, and seizures.
  • Ocular manifestations included optic atrophy and retinitis pigmentosa.
  • Movement disorders such as choreoathetosis, myoclonus, and dystonia were observed.

Findings:

  • Markedly elevated urinary 4-hydroxybutyric acid (300-1000x normal).
  • Associated increases in related organic acids affecting metabolism and beta-oxidation.
  • Vigabatrine therapy rapidly decreased 4-hydroxybutyric acid excretion (80-200x normal).

Related Experiment Videos

Implications:

  • Vigabatrine effectively reduces 4-hydroxybutyric acid levels.
  • Clinical outcomes varied, with only partial improvement in some patients.
  • Further research is needed to understand the disease's complex pathophysiology and treatment responses.